While the effects of VCE-004.8 over multiple sclerosis pathogenesis are CB2R- and PPARγ-independent [90], BCP beneficial effects were reported to depend on CB2R activation at lower concentrations and PPARγ activation at higher concentrations [150]. Here, PPARG is linked to multiple sclerosis.